Literature DB >> 12384012

Methotrexate treatment and mortality in rheumatoid arthritis.

Enrique Rewald, María de las Mercedes Francischetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384012     DOI： 10.1016/s0140-6736(02)11160-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

Authors:  W G Dixon; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2007-01-24       Impact factor: 19.103

2.  Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study.

Authors:  Athanasios N Georgiadis; Eleni C Papavasiliou; Evangelia S Lourida; Yannis Alamanos; Christina Kostara; Alexandros D Tselepis; Alexandros A Drosos
Journal:  Arthritis Res Ther       Date:  2006-04-28       Impact factor: 5.156

3.  The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study.

Authors:  Joo Ran Hong; Hojin Jeong; Hyeongsu Kim; Hyun Suk Yang; Ji Youn Hong; Sung Min Kim; Young Ah Cho; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.